BridgeBio Pharma, Inc. Common Stock (NASDAQ: BBIO) last traded at $81.50, down 1.74% on the session. The quote above updates while this page is open; the figures below are drawn from BridgeBio Pharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
BridgeBio Pharma, Inc. Common Stock trades on NASDAQ under the ticker BBIO. Its market capitalisation is $15.93 billion.
Valuation measures for BridgeBio Pharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $15.93B |
|---|---|
| Enterprise value | $18.98B |
| Price / sales | 22.34 |
| Beta | 1.19 |
Trailing-twelve-month figures tagged in BridgeBio Pharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $713.07M |
|---|---|
| Net income (TTM) | -$702.02M |
| EPS (TTM) | -$3.57 |
| Operating margin | -69.81% |
| Cash | $677.91M |
Range and volume for BBIO over the past 52 weeks.
| 52-week high | $93.42 |
|---|---|
| 52-week low | $46.81 |
| Volume | 1.74M |
| Average volume | 3.29M |
| Previous close | $82.94 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.